Printer Friendly

Rabobank says Arseus' organic growth disappoints.

(SeeNews) - Jul 8, 2011 - Rabobank cheered the second-quarter revenues of Belgian health products wholesaler Arseus (EBR:RCUS), but said it is disappointed with its organic growth.

The bank maintained its "hold" recommendation and EUR 12.50 share price target.

Arseus' second-quarter revenues rose by 12.5% on the year to EUR 121.4 million (USD 174.2m), slightly up from the projected EUR 120.4 million by Rabobank. Organically, revenues grew by 2.7%, while the bank had bet on a 3.5% rise.

The Fagron division achieved the highest organic growth of 6.7%. All other divisions showed a disappointing organic development, according to the bank.

For full 2011, Arseus expects organic revenue growth of 3% to 6%. According to Rabo, the revenue growth is currently at the lower end of the range.

At 1027 CET on Friday Arseus shares gained 2.41% to EUR 11.49 in Brussels trading.

(EUR 1.0 = USD 1.435)
COPYRIGHT 2011 AII Data Processing Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:ADP News Belgium
Date:Jul 8, 2011
Words:157
Previous Article:Arseus sales rise 13.7% Y/Y in H1 2011.
Next Article:Belgian Van de Velde sales rise 9% Y/Y in H1 2011.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters